Polymorphic genes of detoxification and mitochondrial enzymes and risk for progressive supranuclear palsy: a case control study

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1471-2350
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Polymorphic genes of detoxification and mitochondrial enzymes and risk for progressive supranuclear palsy: a case control study ; volume:13 ; number:1 ; day:17 ; month:3 ; year:2012 ; pages:1-9 ; date:12.2012
BMC medical genetics ; 13, Heft 1 (17.3.2012), 1-9, 12.2012

Creator
Potts, Lisa F.
Contributor
Cambon, Alex C.
Ross, Owen A.
Rademakers, Rosa
Dickson, Dennis W.
Uitti, Ryan J.
Wszolek, Zbigniew K.
Rai, Shesh N.
Farrer, Matthew J.
Hein, David W.
Litvan, Irene
SpringerLink (Online service)

DOI
10.1186/1471-2350-13-16
URN
urn:nbn:de:1111-2016071515500
Rights
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 11:01 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Potts, Lisa F.
  • Cambon, Alex C.
  • Ross, Owen A.
  • Rademakers, Rosa
  • Dickson, Dennis W.
  • Uitti, Ryan J.
  • Wszolek, Zbigniew K.
  • Rai, Shesh N.
  • Farrer, Matthew J.
  • Hein, David W.
  • Litvan, Irene
  • SpringerLink (Online service)

Other Objects (12)

The neuropathological diagnosis of Alzheimer’s disease

The neuropathological diagnosis of Alzheimer’s disease

Associations of mitochondrial genomic variation with corticobasal degeneration, progressive supranuclear palsy, and neuropathological tau measures

Associations of mitochondrial genomic variation with corticobasal degeneration, progressive supranuclear palsy, and neuropathological tau measures

Latent trait modeling of tau neuropathology in progressive supranuclear palsy

Latent trait modeling of tau neuropathology in progressive supranuclear palsy

Progressive Supranuclear Palsy

Progressive Supranuclear Palsy

Rainwater Charitable Foundation criteria for the neuropathologic diagnosis of progressive supranuclear palsy

Rainwater Charitable Foundation criteria for the neuropathologic diagnosis of progressive supranuclear palsy

Epigenome-wide DNA methylation profiling in Progressive Supranuclear Palsy reveals major changes at DLX1

Epigenome-wide DNA methylation profiling in Progressive Supranuclear Palsy reveals major changes at DLX1

Replication of progressive supranuclear palsy genome-wide association study identifies SLCO1A2 and DUSP10 as new susceptibility loci

Replication of progressive supranuclear palsy genome-wide association study identifies SLCO1A2 and DUSP10 as new susceptibility loci

Cellular and pathological heterogeneity of primary tauopathies

Cellular and pathological heterogeneity of primary tauopathies

Multireceptor fingerprints in progressive supranuclear palsy

Multireceptor fingerprints in progressive supranuclear palsy

Autonomic dysfunction in progressive supranuclear palsy

Autonomic dysfunction in progressive supranuclear palsy

Cross species systems biology discovers glial DDR2, STOM, and KANK2 as therapeutic targets in progressive supranuclear palsy

Cross species systems biology discovers glial DDR2, STOM, and KANK2 as therapeutic targets in progressive supranuclear palsy

Case report of a patient with unclassified tauopathy with molecular and neuropathological features of both progressive supranuclear palsy and corticobasal degeneration

Case report of a patient with unclassified tauopathy with molecular and neuropathological features of both progressive supranuclear palsy and corticobasal degeneration

Related objects